Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23749 | 23512600 | Obesity (Silver Spring) | Serum hepcidin levels are associated with obesity but not liver disease. | 2013 | Details |
| A23750 | 23510779 | Gene | Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children. | 2013 | Details |
| A23754 | 23509615 | J Obes | Platelet counts and liver enzymes after bariatric surgery. | 2013 | Details |
| A23758 | 23507799 | Nat Rev Gastroenterol Hepatol | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. | 2013 | Details |
| A23759 | 23507574 | Endocrinology | Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis. | 2013 | Details |
| A23760 | 23505183 | Obesity (Silver Spring) | Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women. | 2013 | Details |
| A23762 | 23504985 | Pediatr Obes | Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents. | 2013 | Details |
| A23764 | 23504808 | Hepatology | Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? | 2013 | Details |
| A23770 | 23497552 | BMC Res Notes | Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study. | 2013 | Details |
| A23771 | 23496113 | Pediatr Transplant | Pediatric post-transplant metabolic syndrome: new clouds on the horizon. | 2013 | Details |
| A23772 | 24843641 | J Diabetes Investig | Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas. | 2013 | Details |
| A23775 | 23492103 | Gut | Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. | 2013 | Details |
| A23781 | 23485520 | J Hepatol | The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. | 2013 | Details |
| A23785 | 23482433 | Korean J Pediatr | Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A23786 | 23482247 | World J Gastroenterol | Fructose as a key player in the development of fatty liver disease. | 2013 | Details |
| A23787 | 23480804 | Expert Opin Med Diagn | Liver fibrosis in patients with non-alcoholic fatty liver disease: diagnostic options in clinical practice. | 2012 | Details |
| A23792 | 23478246 | Minerva Gastroenterol Dietol | Liver steatosis in celiac disease: the open door. | 2013 | Details |
| A23793 | 23478245 | Minerva Gastroenterol Dietol | Management of non-alcoholic fatty liver disease. | 2013 | Details |
| A23797 | 23475581 | Curr Diab Rep | Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis. | 2013 | Details |
| A23799 | 23472083 | PLoS One | Hepatic methionine homeostasis is conserved in C57BL/6N mice on high-fat diet despite major changes in hepatic one-carbon metabolism. | 2013 | Details |
| A23806 | 23458891 | Nat Rev Gastroenterol Hepatol | NAFLD in Asia--as common and important as in the West. | 2013 | Details |
| A23810 | 23454028 | Clin Gastroenterol Hepatol | Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. | 2013 | Details |
| A23813 | 23452341 | Br J Clin Pharmacol | The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake. | 2014 | Details |
| A23814 | 23452186 | Clin Microbiol Infect | Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? | 2013 | Details |
| A23815 | 23452163 | Clin Microbiol Infect | Gut microbiota and non-alcoholic fatty liver disease: new insights. | 2013 | Details |
| A23817 | 23451176 | PLoS One | Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis. | 2013 | Details |
| A23820 | 23447513 | Pediatr Obes | Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children. | 2013 | Details |
| A23821 | 23447451 | Hepatology | Desmosterol in human nonalcoholic steatohepatitis. | 2013 | Details |
| A23823 | 23444782 | Pharmazie | Effects of a new sustained-release microsphere formulation of exenatide, DA-3091, on obese and non-alcoholic fatty liver disease mice. | 2013 | Details |
| A23829 | 23442833 | J Clin Gastroenterol | Immune therapy for nonalcoholic steatohepatitis: are we there yet? | 2013 | Details |
| A23834 | 23439771 | Diabetes Metab J | Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. | 2013 | Details |
| A23840 | 23433458 | Adv Pharmacol | Eicosanoids in metabolic syndrome. | 2013 | Details |
| A23841 | 23432982 | Arab J Gastroenterol | Relationship between non-alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration. | 2012 | Details |
| A23845 | 23431468 | ISRN Endocrinol | Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease. | 2013 | Details |
| A23846 | 23431426 | J Obes | Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? | 2013 | Details |
| A23847 | 23431294 | Int J Endocrinol | Hepatic steatosis and thyroid function tests in overweight and obese children. | 2013 | Details |
| A23850 | 23430039 | World J Gastroenterol | What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? | 2013 | Details |
| A23851 | 23426824 | J Pediatr Endocrinol Metab | Obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population. | 2012 | Details |
| A23852 | 23426822 | J Pediatr Endocrinol Metab | Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. | 2012 | Details |
| A23854 | 23426707 | Exp Clin Endocrinol Diabetes | Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease. | 2013 | Details |
| A23861 | 23424924 | Rev Prat | [Epidemiology and natural history of nonalcoholic fatty liver disease]. | 2012 | Details |
| A23864 | 23419824 | J Hepatol | The burden of liver disease in Europe: a review of available epidemiological data. | 2013 | Details |
| A23867 | 23418085 | Obesity (Silver Spring) | Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. | 2013 | Details |
| A23868 | 23418072 | Obesity (Silver Spring) | A metabolically healthy obese phenotype in hispanic participants in the IRAS family study. | 2013 | Details |
| A23874 | 23411507 | Endocr J | High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. | 2013 | Details |
| A23877 | 23406705 | Pediatr Exerc Sci | Cardiorespiratory fitness, but not central obesity or C-reactive protein, is related to liver function in obese children. | 2013 | Details |
| A23880 | 23406154 | Lipids Health Dis | Effect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice. | 2013 | Details |
| A23881 | 23405890 | Clin Endocrinol (Oxf) | Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders. | 2013 | Details |
| A23884 | 23404955 | Obesity (Silver Spring) | Alterations in adipocytokines and cGMP homeostasis in morbid obesity patients reverse after bariatric surgery. | 2013 | Details |
| A23888 | 23401753 | J Obes | Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice. | 2013 | Details |
| A23889 | 23401313 | Hepatology | Intestinal microbiota in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23894 | 23398201 | Biol Cell | PNPLA3/adiponutrin functions in lipid droplet formation. | 2013 | Details |
| A23895 | 23360884 | Br J Nutr | Gut microbiota and metabolic disorders: How prebiotic can work? | 2013 | Details |
| A23896 | 23397556 | Semin Thromb Hemost | Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. | 2013 | Details |
| A23897 | 23397532 | Semin Liver Dis | A critical appraisal of advances in pediatric nonalcoholic Fatty liver disease. | 2013 | Details |
| A23903 | 23394097 | Curr Pharm Des | Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. | 2013 | Details |
| A23905 | 23394095 | Curr Pharm Des | The role of lifestyle change in the prevention and treatment of NAFLD. | 2013 | Details |
| A23909 | 23394091 | Curr Pharm Des | Epidemiology and natural history of patients with NAFLD. | 2013 | Details |
| A23913 | 23391869 | J Clin Gastroenterol | The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23917 | 23390441 | Korean J Pediatr | The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice. | 2013 | Details |
| A23918 | 23390127 | Hepatology | Dietary fructose in nonalcoholic fatty liver disease. | 2013 | Details |
| A23920 | 23389749 | Food Funct | Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-γ and SREBP-1c in diet-induced obese mice. | 2013 | Details |
| A23922 | 23387384 | Obes Rev | Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. | 2013 | Details |
| A23924 | 23385644 | J Mol Med (Berl) | Lack of kinin B₁ receptor potentiates leptin action in the liver. | 2013 | Details |
| A23935 | 23374505 | Hepatol Res | Derangement of ghrelin secretion after long-term high-fat diet feeding in rats. | 2013 | Details |
| A23937 | 23371785 | Plant Foods Hum Nutr | Oat prevents obesity and abdominal fat distribution, and improves liver function in humans. | 2013 | Details |
| A23939 | 23370355 | Biol Pharm Bull | A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis. | 2013 | Details |
| A23943 | 23367495 | J Clin Res Pediatr Endocrinol | Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. | 2013 | Details |
| A23944 | 23367494 | J Clin Res Pediatr Endocrinol | High-sensitivity C-reactive protein levels and metabolic disorders in obese and overweight children and adolescents. | 2013 | Details |
| A23946 | 23363012 | Ann N Y Acad Sci | Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. | 2013 | Details |
| A23949 | 23357341 | J Genet Genomics | Genetics of nonalcoholic Fatty liver disease: an overview. | 2012 | Details |
| A23951 | 23355916 | World J Hepatol | Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. | 2012 | Details |
| A23955 | 23353640 | Clin Gastroenterol Hepatol | External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. | 2013 | Details |
| A23956 | 23352496 | J Diabetes Complications | Potential of incretin-based therapies for non-alcoholic fatty liver disease. | 2013 | Details |
| A23959 | 23351585 | J Clin Lipidol | Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction. | 2012 | Details |
| A23960 | 23348961 | Gut | Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice. | 2013 | Details |
| A23963 | 23347840 | Clin Res Hepatol Gastroenterol | Non-alcoholic steatohepatitis in morbidly obese patients. | 2013 | Details |
| A23965 | 23346152 | Hepat Mon | First National Report on Aminotransaminases' Percentiles in Children of the Middle East and North Africa (MENA): the CASPIAN-III Study. | 2012 | Details |
| A23968 | 23344895 | Pediatr Cardiol | Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease. | 2013 | Details |
| A23969 | 23340336 | Br J Nutr | Carbohydrate quality is not associated with liver enzyme activity and plasma TAG and HDL concentrations over 5 years in an older population. | 2013 | Details |
| A23972 | 23334462 | Diabetologia | Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3. | 2013 | Details |
| A23978 | 23329754 | J Pediatr Endocrinol Metab | A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents. | 2012 | Details |
| A23979 | 23329465 | Drugs | Nonalcoholic fatty liver disease: current issues and novel treatment approaches. | 2013 | Details |
| A23981 | 23329217 | Arq Gastroenterol | Risk factors for nonalcoholic steatohepatitis in cryptogenic cirrhosis. | 2012 | Details |
| A23982 | 23329013 | Dig Dis Sci | Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease. | 2013 | Details |
| A23985 | 23326306 | PLoS One | Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India. | 2013 | Details |
| A23994 | 23320150 | J Obes | Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? | 2012 | Details |
| A23995 | 23320041 | Evid Based Complement Alternat Med | Study of the effects of monacolin k and other constituents of red yeast rice on obesity, insulin-resistance, hyperlipidemia, and nonalcoholic steatohepatitis using a mouse model of metabolic syndrome. | 2012 | Details |
| A23999 | 23315950 | Hepatology | Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. | 2013 | Details |
| A24003 | 23312215 | J Diabetes Complications | Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. | 2013 | Details |
| A24006 | 23305254 | Int J Exp Pathol | An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. | 2013 | Details |
| A24008 | 23304532 | Int J Hepatol | Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease. | 2012 | Details |
| A24009 | 23304464 | J Obes | The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome. | 2012 | Details |
| A24011 | 23303872 | J Nutr | Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. | 2013 | Details |
| A24017 | 23299992 | Hepatology | Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. | 2013 | Details |
| A24018 | 23299969 | Hepatology | Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. | 2013 | Details |
| A24027 | 23294957 | Chirurgia (Bucur) | Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. | 2013 | Details |
| A24029 | 23294790 | J Diabetes Sci Technol | A simple Indian diabetes risk score could help identify nondiabetic individuals at high risk of non-alcoholic fatty liver disease (CURES-117). | 2012 | Details |
| A24033 | 23293250 | BMJ Open | Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study. | 2013 | Details |
| A24037 | 23293196 | Ann Hepatol | Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study. | 2013 | Details |